May 23, 2020
Sanofi, Regeneron’s Dupixent trial meets both co-primary endpoints
Dupixent in patients 12 years and older with eosinophilic esophagitis (EoE) trial met both of its co-primary endpoints.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
May 23, 2020
Ipsen surveys give insight into the real-life burden of spasticity or cervical dystonia
Ipsen’s results reveal the need for longer-lasting symptoms control to improve patients’ perceived quality of life
May 22, 2020
Teva has new Ajovya nalyses and latest Copaxone Data
Teva will present new data on Ajovy and on the long-term safety and efficacy of Copaxone at at the 6th Congress of the European Academy of Neurology
May 21, 2020
Indica Labs, Octo and Axle work with NIH to launch a global COVID-19 digital pathology repository
Indica Labs and Octo have announced online COVID Digital Pathology Repository (COVID-DPR), a virtual collection of high resolution microscopic COVID-related human tissue images hosted at the National Institutes of Health.
May 21, 2020
EDIT: Removed press release
EDIT: Juvenescence put out a press release in error on May 21st, and it has been removed.
May 20, 2020
Virpax scores at the pre-IND meeting with FDA on Epoladerm for Knee Osteoarthritis
Virpax Pharmaceuticals has successfully completed a pre-Investigational New Drug (IND) Application meeting with the U.S. Food and Drug Administration (FDA)…
May 18, 2020
Alvotech welcomes deputy CEO in Iceland
Alvotech has named Tanya Zharov as deputy chief executive officer in Iceland to oversee Icelandic operations and administration, including the Reykjavik site leadership team, human resources, business operations, shared services and facilities.
May 18, 2020
Avacopan new focus for VFMCRP and ChemoCentryx, CCX140 won’t move forward in FSGS
In the study, CCX140 did not demonstrate a meaningful reduction in proteinuria relative to the control group after 12 weeks of blinded treatment.
May 15, 2020
Avacta Develops SARS-COV-2 Neutralising Affimer Reagents with Therapeutic Potential for COVID-19
Avacta said that Affimer reagents recently generated for development of a point-of-care COVID-19 antigen saliva test have now also been shown to block the interaction between the virus’ spike protein and ACE2, a receptor on human cells that is key to the virus infection pathway.
May 15, 2020
Transgene, NEC algorithm looks accurate in spotting cancer mutations
T G4050 is being evaluated in two Phase 1 clinical trials. It combines Transgene’s proprietary myvac® platform with NEC’s cutting-edge…